Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-4598

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment ; volume:18 ; number:1 ; day:30 ; month:3 ; year:2019 ; pages:1-19 ; date:12.2019
Molecular cancer ; 18, Heft 1 (30.3.2019), 1-19, 12.2019

Creator: Cheng, Hong Sheng
Lee, Jeannie Xue Ting
Wahli, Walter
Tan, Nguan Soon

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12943-019-0971-9

URN: urn:nbn:de:101:1-2019042112291773507059

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cheng, Hong Sheng
Lee, Jeannie Xue Ting
Wahli, Walter
Tan, Nguan Soon
SpringerLink (Online service)

Other Objects (12)

Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma

Exploiting molecular vulnerabilities in genetically defined lung cancer models

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Vulnerabilities

Hochschulschrift

Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma

Exploiting molecular vulnerabilities in genetically defined lung cancer models

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Vulnerabilities

Hochschulschrift

Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma

Exploiting molecular vulnerabilities in genetically defined lung cancer models

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Vulnerabilities

Hochschulschrift

Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma

Exploiting molecular vulnerabilities in genetically defined lung cancer models

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Vulnerabilities

Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma

Exploiting molecular vulnerabilities in genetically defined lung cancer models

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Vulnerabilities

Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma

Exploiting molecular vulnerabilities in genetically defined lung cancer models

Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality

Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

Vulnerabilities

Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs

Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

Related objects

Reset password